Literature DB >> 18295538

BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.

Yiping Chen1, Jennifer Trofe, Jennifer Gordon, Patrick Autissier, E Steve Woodle, Igor J Koralnik.   

Abstract

BACKGROUND: BK virus (BKV), which causes polyomavirus-associated nephropathy (PVN) in kidney transplant recipients (KTx), has 75% homology with JC virus (JCV), the etiologic agent of progressive multifocal leukoencephalopathy (PML). The large T-antigen (T-ag) is the main regulatory protein of polyomaviruses that is expressed early in the viral cycle.
OBJECTIVES: To characterize epitopes of BKV and JCV T-ag recognized by CD8+ T-cells and explore the role of these cells in containing polyomavirus infection. STUDY
DESIGN: We tested peripheral blood mononuclear cells of HLA A*0201+ BKV- and JCV-seropositive individuals, including patients with active BKV or JCV infection and healthy control subjects in a cross-sectional study.
RESULTS: CD8+ T-cells that recognized the nonamer BKV Tp579, which is identical to JCV Tp578, were detected by tetramer staining in 10/13 (77%) healthy individuals, 3/10 (30%) KTx/PVN, and 4/9 (44%) patients with PML and/or HIV-infection. Conversely, BKV Tp398- and Tp410-specific CD8+ T cells were detected in 3/13 (23%) and 1/13 (8%) healthy individuals only.
CONCLUSION: These data suggest that, as it is the case for the VP1 protein, the same population of CD8+ T-cells may recognize epitopes located on the BKV and JCV T protein. The overall cellular immune response against polyomavirus T-ag, however, is lower than against the VP1 protein and is more frequently detected in healthy individuals than in patients with active BKV or JCV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295538      PMCID: PMC2678795          DOI: 10.1016/j.jcv.2008.01.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  12 in total

1.  Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients.

Authors:  Parmjeet S Randhawa; Iulia Popescu; Camila Macedo; Adriana Zeevi; Ron Shapiro; Abhay N Vats; Diana Metes
Journal:  Hum Immunol       Date:  2006-04-07       Impact factor: 2.850

2.  Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

Authors:  Igor J Koralnik; Renaud A Du Pasquier; Marcelo J Kuroda; Jörn E Schmitz; Xin Dang; Yue Zheng; Michelle Lifton; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.

Authors:  Madeva C Sharma; Wendy Zhou; Joy Martinez; Ludmila Krymskaya; Tumul Srivastava; Wahajul Haq; Don J Diamond; Simon F Lacey
Journal:  Virology       Date:  2006-04-05       Impact factor: 3.616

5.  Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients.

Authors:  S Binggeli; A Egli; S Schaub; I Binet; M Mayr; J Steiger; H H Hirsch
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

6.  Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

Authors:  Ludmila Krymskaya; Madeva C Sharma; Joy Martinez; Wahajul Haq; Eric C Huang; Ajit P Limaye; Don J Diamond; Simon F Lacey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Renaud A Du Pasquier; Prabir Roy-Chaudhury; Marcelo J Kuroda; E Steve Woodle; Kamel Khalili; Igor J Koralnik
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Yue Zheng; Jims Jean-Jacques; Norman L Letvin; Igor J Koralnik
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

9.  Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Joern E Schmitz; Yue Zheng; Kristi Martin; Fred W Peyerl; Michelle Lifton; Darci Gorgone; Patrick Autissier; Norman L Letvin; Igor J Koralnik
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.

Authors:  Maurizio Provenzano; Laura Bracci; Stephen Wyler; Tvrtko Hudolin; Giovanni Sais; Rainer Gosert; Paul Zajac; Giorgio Palu'; Michael Heberer; Hans H Hirsch; Giulio C Spagnoli
Journal:  J Transl Med       Date:  2006-11-10       Impact factor: 5.531

View more
  9 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

Review 3.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.

Authors:  Christian Wüthrich; Stephanie Batson; Igor J Koralnik
Journal:  J Neuropathol Exp Neurol       Date:  2015-08       Impact factor: 3.685

5.  HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Diana Metes; Marta Bueno; Adriana Zeevi; Ron Shapiro; Raphael Viscidi; Parmjeet S Randhawa
Journal:  Hum Immunol       Date:  2009-05-14       Impact factor: 2.850

6.  Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Kirstin M Heutinck; Anja ten Brinke; Hanspeter Pircher; René A W van Lier; Ineke J M ten Berge
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

7.  Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Kirstin M Heutinck; Anja Ten Brinke; Mariet C W Feltkamp; Neelke C van der Weerd; Karlijn A M I van der Pant; Frederike J Bemelman; René A W van Lier; Ineke J M Ten Berge
Journal:  PLoS Pathog       Date:  2016-10-10       Impact factor: 6.823

Review 8.  The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.

Authors:  Martyn K White; Jennifer Gordon; Kamel Khalili
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

9.  Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.

Authors:  M Cioni; C Leboeuf; P Comoli; F Ginevri; H H Hirsch
Journal:  Am J Transplant       Date:  2016-02-17       Impact factor: 8.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.